Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Other Non-Current Assets (2009 - 2026)

Updated

Sanofi's Other Non-Current Assets was $5.5 billion in the quarter ended Jun 30, 2026, up 18.3% from $4.65 billion a year earlier and up 639.9% from the prior quarter.

Analysis

Sanofi (SNY) Other Non-Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Other Non-Current Assets at Sanofi came in at $4.93 billion, up 21.4% from the prior year.

  • Other Non-Current Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 9.6% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Other Non-Current Assets was $4.06 billion in the year ended Dec 31, 2024 (+16.7%), $3.48 billion in the year ended Dec 31, 2023 (+6.7%), $3.26 billion in the year ended Dec 31, 2022 (-11.8%) and $3.7 billion in the year ended Dec 31, 2021 (+18.5%).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Other Non-Current Assets since the quarter ended Mar 31, 2025.
  • Compared with a year earlier, Other Non-Current Assets was higher in four of the last five quarters, with an average decline of 0.9%.
  • The best year-over-year quarter for Other Non-Current Assets over five years was the quarter ended Jun 30, 2025 (growth of 29.6%); the worst was the quarter ended Mar 31, 2026 (a decline of 94.9%).
  • Per Business Quant data, SNY's Other Non-Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $743.42 million (quarter ended Mar 31, 2026), $5.08 billion (quarter ended Dec 31, 2025) and $161.33 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 15.10 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 10.73 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 4.75 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 9.94 Bn
10 Sanofi 51.17 Bn 18.10 Bn 10.79 Bn 5.40 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.40 Bn
Mar 31, 2026 727.71 Mn
Dec 31, 2025 5.13 Bn
Sep 30, 2025 161.89 Mn
Jun 30, 2025 4.82 Bn
Mar 31, 2025 14.86 Bn
Dec 31, 2024 3.91 Bn
Jun 30, 2024 3.57 Bn
Dec 31, 2023 3.56 Bn
Jun 30, 2023 3.25 Bn
Dec 31, 2022 3.30 Bn
Jun 30, 2022 3.46 Bn
Dec 31, 2021 3.54 Bn
Jun 30, 2021 3.21 Bn
Dec 31, 2020 3.36 Bn
Jun 30, 2020 3.41 Bn
Dec 31, 2019 2.80 Bn
Jun 30, 2019 2.57 Bn
Dec 31, 2018 3.22 Bn
Sep 30, 2018 1.16 Mn
API Access

Sanofi Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SNY&period=max&api_key=YOUR_API_KEY